Myocardial creatine concentration in various nonischemic heart diseases assessed by1H magnetic resonance spectroscopy

Circulation Journal

Volumn 69, Issue 6, 2005, Pages 711-716

  Nakae, Ichiro ^a   Mitsunami, Kenichi ^a   Matsuo, Shinro ^a   Inubushi, Toshiro ^a   Morikawa, Shigehiro ^a   Tsutamoto, Takayoshi ^a   Koh, Terue ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Creatine; Heart failure; Magnetic resonance spectroscopy

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART AMYLOIDOSIS; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MALE; NON INVASIVE MEASUREMENT; PREDICTION; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS; RESTRICTIVE CARDIOMYOPATHY; VALVULAR HEART DISEASE;

ADULT; AGED; CREATINE; FEMALE; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 20444418199     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.711     Document Type: Article

References (30)

1. Schaefer S. Magnetic resonance spectroscopy in human cardiomyopathies. J Cardiovasc Magn Resort 2000; 2: 151-157.
2. 31P Magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992; 86: 1810-1818.
3. 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur Heart J 1995; 16: 115-118.
4. 11P magnetic resonance spectroscopy. Lancet 1991; 338: 973-976.
5. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-2196.
6. Bottomley PA, Weiss RG. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998; 351: 714-718.
7. Bottomley PA, Weiss RG. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology 2001; 219: 411-418.
8. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508: 333-348.
9. 1H magnetic resonance spectroscopic imaging. Magn Reson Med 1994; 32: 175-180.
10. Forder JR, Pohost GM. Cardiovascular nuclear magnetic resonce: Basic and clinical applications. J Clin Invest 2003; 111: 1630-1639.
11. Bottomley PA, Lee YH, Weiss RG. Total creatine in muscle: Imaging and quantification with proton MR spectroscopy. Radiology 1997; 204: 403-410.
12. Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by ID-resolved NMR spectrosopy. Magn Reson Med 1996; 35: 664-670.
13. Snyder WS, Cook MJ, Nasset ES. Report of the task group on reference man. International commision on radiological protection, No. 23. Oxford: Pergamon Press; 1984; 116.
14. 31P NMR surface coil studies in brain, heart, and skeletal muscle of the living rat. Biochemistry 1987;26:6083-6090.
15. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993; 87(Suppl VII): VII-58-VII-62.
16. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996; 94: 1894-1901.
17. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy: Relationship to contractile performance. Circ Res 1996; 78: 893-902.
18. 31P Nuclear magnetic resonance spectroscopy: A noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in humans. Am J Cardiol 1999;83: 19H-24H.
19. de Roos A, Doornbos J, Luyten PR, Oosterwaal LJMP, van der Wall EE, den Hollander JA. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: Assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 1992; 2: 711-719.
20. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998; 97: 2536-2542.
21. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 1990; 323: 1593-1600.
22. 31P MRS. Magn Reson Med 1998; 39: 772-782.
23. Neubauer S, Remkes H, Spindler M, Horn M, Wiesmann F, Prestle J, et al. Downregulation of the Na+-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation 1999; 100: 1847-1850.
24. Lee CW, Lee JH, Kim JJ, Park SW, Hong MK, Kim ST, et al. Cerabral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 1999; 33: 1196-1202.
25. 31P Nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1987; 60: 309-315.
26. Okita K, Yonezawa K, Nishijima H, Hanada A, Ohtsubo M, Kohya T, et al. Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 1886-1891.
27. Nagai T, Okita K, Yonezawa K, Yamada Y, Hanada A, Ohtsubo M, et al. Comparisons of the skeletal muscle metabolic abnormalities in the arm and leg muscles of patients with chronic heart failure. Circ J 2004; 68: 573-579.
28. Takaoka A, Nakae I, Mitsunami K, Yabe T, Morikawa S, Inubushi T, et al. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: Effects of "remote preconditioning". J Am Coll Cardiol 1999; 33: 556-564.
29. Yamaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H, et al. Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. Circ J 2003; 67: 253-258.
30. Wakahara N, Katoh H, Yamaguchi Y, Uehara A, Satoh H, Terada H, et al. Difference in the cardioprotective mechanisms between ischemic preconditioning and pharmacological preconditioning by diazoxide in rat hearts. Circ J 2004; 68: 156-162.